Literature DB >> 3003262

Dopamine action in the nucleus accumbens.

J F DeFrance, R W Sikes, R B Chronister.   

Abstract

The action of dopamine was studied in the nucleus accumbens of acutely prepared rabbits. Dopamine was applied iontophoretically to those cells and cell populations that responded in a monosynaptic excitatory manner to ipsilateral fimbrial stimulation. This strategy was adopted to isolate the effects of dopamine on postsynaptic receptors thus avoiding the bias resulting from activation of presynaptic dopamine receptors on dopaminergic afferents. Dopamine was found to have a suppressive effect on the excitatory (N) component of the field response and on driven extracellular unitary discharges. The specificity of dopamine's effect with receptors was indicated by the facts that fluphenazine effectively antagonized dopamine's effect, whereas bicuculline did not. The effect of dopamine was dependent on the rate of fimbrial stimulation. Dopamine has a marked suppressive effect on the fimbria-induced response at 0.5 Hz of stimulation but not at 6.0 Hz. This frequency specificity could not be linked directly to a cyclic adenosine 3',5'-cyclic monophosphate (cyclic AMP) mechanism because the iontophoresis cyclic AMP and dibutyryl cyclic AMP had suppressive effects at both 0.5 and 6.0 Hz rates of stimulation. It is suggested that dopamine acts in the nucleus accumbens to increase the "signal-to-noise" ratio. This might be a form of "contrast enhancement" of an incoming hippocampal message.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3003262     DOI: 10.1152/jn.1985.54.6.1568

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  13 in total

1.  Dopamine depresses excitatory and inhibitory synaptic transmission by distinct mechanisms in the nucleus accumbens.

Authors:  S M Nicola; R C Malenka
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  Dopaminergic modulation of prefrontal cortical input to nucleus accumbens neurons in vivo.

Authors:  Anne Marie Brady; Patricio O'Donnell
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

3.  Distribution of amygdala input to the nucleus accumbens septi: an electrophysiological investigation.

Authors:  C W Callaway; R L Hakan; S J Henriksen
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 4.  Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.

Authors:  Antonio Alcaro; Robert Huber; Jaak Panksepp
Journal:  Brain Res Rev       Date:  2007-08-21

5.  Modulation of hippocampal and amygdalar-evoked activity of nucleus accumbens neurons by dopamine: cellular mechanisms of input selection.

Authors:  S B Floresco; C D Blaha; C R Yang; A G Phillips
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

6.  Cocaine effects in the ventral tegmental area: evidence for an indirect dopaminergic mechanism of action.

Authors:  M S Brodie; T V Dunwiddie
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

7.  Differential effects of acute and repeated stress on hippocampus and amygdala inputs to the nucleus accumbens shell.

Authors:  Kathryn M Gill; Anthony A Grace
Journal:  Int J Neuropsychopharmacol       Date:  2013-06-10       Impact factor: 5.176

8.  Enhancement of dopamine actions on rat nucleus accumbens neurones in vitro after methamphetamine pre-treatment.

Authors:  H Higashi; K Inanaga; S Nishi; N Uchimura
Journal:  J Physiol       Date:  1989-01       Impact factor: 5.182

9.  Altered short-term plasticity in the prefrontal cortex after early life seizures.

Authors:  A E Hernan; G L Holmes; D Isaev; R C Scott; E Isaeva
Journal:  Neurobiol Dis       Date:  2012-10-12       Impact factor: 5.996

10.  Electrophysiological evidence of mediolateral functional dichotomy in the rat accumbens during cocaine self-administration: tonic firing patterns.

Authors:  Anthony T Fabbricatore; Udi E Ghitza; Volodymyr F Prokopenko; Mark O West
Journal:  Eur J Neurosci       Date:  2009-12-10       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.